Company news
Spectral Medical Inc news in 2026
Spectral Medical Inc's news releases, calls and decks from 2026, newest first.
Spectral Medical Inc. Announces Closing of Second Tranche of $14.0 Million Convertible Note Private Placement
November 6, 2026
Spectral Medical Announces Third Quarter 2026 Financial Results and Provides Corporate Update
November 6, 2026
Spectral Medical Inc. Announces Closing of First Tranche of $14.0 Million Convertible Note Private Placement, Conversion of US$4.5 Million of Maturing Convertible Notes and Repayment of US$4.5 Million of Maturing Convertible Notes
November 2, 2026
Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting for PMX PMA
September 11, 2026
Spectral Medical Announces Second Quarter 2026 Financial Results and Provides Corporate Update
August 7, 2026
Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX
June 25, 2026
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders
June 9, 2026
Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral's Tigris Trial
June 4, 2026
Spectral Medical Announces PMA Submission to U.S. FDA for PMX
May 29, 2026
Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 8, 2026
Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
April 1, 2026
Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update
March 26, 2026
Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine
March 24, 2026
Spectral Medical Provides Update on PMA Submission Timing for PMX-20R
February 26, 2026